Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients

Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics

(2013) Philip J. Mease et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Impact of effective tumor necrosis factor-alfa inhibitor treatment on arterial intima-media thickness in psoriasis: Results of a pilot study

(2013) Hajnalka Jókai et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

(2013) Iain B McInnes et al.   LANCET

Ustekinumab Associated With Flares of Psoriatic Arthritis

(2013) Emily F. Stamell et al.   JAMA Dermatology

Inflammatory arthritis following ustekinumab treatment for psoriasis: a report of two cases

(2012) A. de Souza et al.   BRITISH JOURNAL OF DERMATOLOGY

Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years

(2012) A.B. Kimball et al.   BRITISH JOURNAL OF DERMATOLOGY

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial

(2009) Alice Gottlieb et al.   LANCET

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)

(2008) P J Mease et al.   ANNALS OF THE RHEUMATIC DISEASES